Network Meta-analysis of efficacy and safety of Chinese patent medicines in treatment of ankylosing spondylitis.
10.19540/j.cnki.cjcmm.20220106.501
- Author:
Jun-Yu FAN
1
;
Cen CHANG
1
;
Ying-Ying QIN
1
;
Ting JIANG
1
;
Dong-Yi HE
1
Author Information
1. Guanghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai 200052, China.
- Publication Type:Meta-Analysis
- Keywords:
Chinese patent medicine;
ankylosing spondylitis;
efficacy;
network Meta-analysis;
safety
- MeSH:
Capsules;
China;
Drugs, Chinese Herbal/adverse effects*;
Humans;
Network Meta-Analysis;
Nonprescription Drugs/therapeutic use*;
Spondylitis, Ankylosing/drug therapy*
- From:
China Journal of Chinese Materia Medica
2022;47(8):2211-2227
- CountryChina
- Language:Chinese
-
Abstract:
To evaluate the efficacy and safety of Chinese patent medicines in the treatment of ankylosing spondylitis(AS) by frequency network Meta-analysis. Randomized controlled trials(RCTs)of Chinese patent medicines for AS were retrieved from CNKI, Wanfang, VIP, CBM, PubMed, EMbase and Cochrane Library databases from the time of database establishment to January 2021. The quality of the included RCTs was evaluated according to the Cochrane bias risk standard, and the data was analyzed by RevMan 5.3 and Stata/MP 15.1. A total of 12 kinds of Chinese patent medicines in 55 RCTs were included. According to Meta-analysis, in term of the effectiveness, the top three optimal medication regimens were Biqi Capsules, Yishen Juanbi Pills and Yaobitong Capsules combined with western medicine. The top three interventions to reduce the erythrocyte sedimentation rate(ESR)were Yishen Juanbi Pills, Xianling Gubao Capsules and Fufang Xuanju Capsules combined with western medicine. The top three interventions to reduce the C-reactive protein(CRP)were Biqi Capsules, Xianling Gubao Capsules and Fufang Xuanju Capsules combined with western medicine. In terms of the safety, top three optimal medication regimens were Total Glucosides of Paeony Capsules, Yishen Juanbi Pills, and Wangbi Tablets combined with western medicine. This network Meta-analysis suggests that Chinese patent medicines combined with conventional western medicine can effectively improve the joint pain symptoms of AS patients and reduce the acute inflammatory indicators, with high safety. However, the literature included in this study is generally of low methodological quality, and the conclusion needs to be verified by high-quality research.
